Invention Grant
- Patent Title: Reduction of platelet interference in plasma assay samples
- Patent Title (中): 降低血浆测定样品中的血小板干扰
-
Application No.: US11685289Application Date: 2007-03-13
-
Publication No.: US07767465B2Publication Date: 2010-08-03
- Inventor: Bin Zhang , E. Sabrinah Chapman-Montgomery , Edward P. Kang
- Applicant: Bin Zhang , E. Sabrinah Chapman-Montgomery , Edward P. Kang
- Applicant Address: US NY Tarrytown
- Assignee: Siemens Healthcare Diagnostics Inc
- Current Assignee: Siemens Healthcare Diagnostics Inc
- Current Assignee Address: US NY Tarrytown
- Agency: Woodcock Washburn
- Agent Noam R. Pollack
- Main IPC: G01N1/00
- IPC: G01N1/00

Abstract:
The present invention relates to compositions for improving assay accuracy for plasma samples by decreasing or eliminating false results due to platelet interference. The compositions of the present invention comprise compositions that include a platelet interference reducing agent in an amount effective to decrease the platelet interference activity in the plasma sample, particularly platelet-rich plasma sample, to be analyzed. The most preferred platelet interference reducing agent of the present invention is 1-(1,3-Bis(hydroxymethyl-2,5-dioxoimidazolidin-4-iyl)-1,3-bis(hydroxymethyl) urea, also called “Diazolidinyl urea” or “DZU”.
Public/Granted literature
- US20070224651A1 Reduction Of Platelet Interference In Plasma Assay Samples Public/Granted day:2007-09-27
Information query